11-59652476-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152716.3(PATL1):c.1414G>T(p.Ala472Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,460,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152716.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PATL1 | NM_152716.3 | c.1414G>T | p.Ala472Ser | missense_variant | 11/19 | ENST00000300146.10 | NP_689929.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PATL1 | ENST00000300146.10 | c.1414G>T | p.Ala472Ser | missense_variant | 11/19 | 1 | NM_152716.3 | ENSP00000300146.9 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134868
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1460908Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 726720
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.1414G>T (p.A472S) alteration is located in exon 11 (coding exon 11) of the PATL1 gene. This alteration results from a G to T substitution at nucleotide position 1414, causing the alanine (A) at amino acid position 472 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at